Pentagastrin test for anxiety - Psychophysiology and personality

Psychopharmacology

Volumn 166, Issue 2, 2003, Pages 139-145

  Radu, Diana ^a   Åhlin, Arne ^a   Svanborg, Pär ^a   Lindefors, Nils ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anxiety; C peptide; CCKB receptor; Panic; Pentagastrin; Personality

Indexed keywords

C PEPTIDE; CHOLECYSTOKININ B RECEPTOR; PENTAGASTRIN;

ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEAR; FEMALE; HAMILTON SCALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; INSULIN RELEASE; MALE; NORMAL HUMAN; PANIC; PERSONALITY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RECEPTOR SENSITIVITY; SKIN MANIFESTATION;

EID: 0037335332     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1316-7     Document Type: Article

References (43)

1. Abelson JL, Nesse RM (1994) Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Biol Psychiatry 36:73-83
2. Abelson JL, Nesse RM, Vinik A (1991) Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder. Biol Psychiatry 29:1220-1223
3. Aluoja A, Shlik J, Vasar V, Kingisepp PH, Jagomagi K, Vasar E, Bradwejn J (1997) Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers. Psychiatry Res 66:59-67
4. Antony MM, Brown TA, Barlow DH (1997) Response to hyperventilation and 5.5% CO2 inhalation of subjects with types of specific phobia, panic disorder, or no mental disorder. Am J Psychiatry 154:1089-1095
5. Bland M (2000) An introduction to medical statistics, 3rd edn. Oxford University Press, New York
6. Bradwejn J, Koszycki D, Meterissian G (1990) Cholecystokinintetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35:83-85
7. Bradwejn J, Koszycki D, Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry 48:603-610
8. Bradwejn J, Koszycki D, Annable L, Couetoux du Tertre A, Reines S, Karkanias C (1992) A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Biol Psychiatry 32:903-912
9. Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, Ware MR, He Q, Ballenger JC (1997) Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry 154:700-702
10. Bystritsky A, Craske M, Maidenberg E, Vapnik T, Shapiro D (2000) Autonomic reactivity of panic patients during a CO2 inhalation procedure. Depress Anxiety 11:15-26
11. Cox BJ, Endler NS, Swinson RP (1995) Anxiety sensitivity and panic attack symptomatology. Behav Res Ther 33:833-836
12. de Leeuw AS, Den Boer JA, Slaap BR, Westenberg HG (1996) Pentagastrin has panic-inducing properties in obsessive compulsive disorder. Psychopharmacology 126:339-344
13. de Montigny C (1989) Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch Gen Psychiatry 46:511-517
14. Eke M, McNally RJ (1996) Anxiety sensitivity, suffocation fear, trait anxiety, and breath-holding duration as predictors of response to carbon dioxide challenge. Behav Res Ther 34:603-607
15. First M, Gibbon M, Spitzer R, Williams J (1998a) Structured clinical interview for DSM-IV, axis I disorders (SCID-I). Clinical version. Administration Booklet. Pilgrim Press, Danderyd, Sweden
16. First M, Gibbon M, Spitzer R, Williams J (1998b) Structured clinical interview for DSM-IV, axis I disorders (SCID-I). Research version. Pilgrim Press, Danderyd, Sweden
17. First M, Gibbon M, Spitzer R, Williams J, Benjamin L (1998c) Structured clinical interview for DSM-IV, axis II personality disorders (SCID-II). Pilgrim Press, Danderyd, Sweden
18. Forsyth JP, Palav A, Duff K (1999) The absence of relation between anxiety sensitivity and fear conditioning using 20% versus 13% CO2-enriched air as unconditioned stimuli. Behav Res Ther 37:143-153
19. Gustavsson JP, Åsberg M, Schalling D (1997) The healthy control subject in psychiatric research: impulsiveness and volunteer bias. Acta Psychiatr Scand 96:325-328
20. Gustavsson JP (1997) Stability and validity of self-reported personality traits. Contribution to the evaluation of the Karolinska scales of personality (Ph.D. thesis). Karolinska Institutet, Stockholm, Sweden
21. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
22. Hellstadius A-C (2000) Psykometrisk utprövning av Anxiety Sensitivity Index (Psychometric Evaluation of Anxiety Sensitivity Index). Stockholm: Psykologiska Institutionen, Stockholms Universitet (Department of Psychology, University of Stockholm)
23. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, Fourie O (1999) Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4:284-285
24. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19
25. Koszycki D, Bradwejn J (2001) Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorder. Psychiatry Res 101:137-143
26. Koszycki D, Zacharko RM, Bradwejn J (1996) Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder. Psychiatry Res 62:131-138
27. Ley R (1991) Ventilatory control of heart rate during inhalation of 5% CO2 and types of panic attacks. J Behav Ther Exp Psychiatry 22:193-201
28. Lilienfeld SO, Jacob RG. Turner SM (1989) Comment on Holloway and McNally's (1987) "Effects of anxiety sensitivity on the response to hyperventilation". J Abnorm Psychol 98:100-102
29. Lines C, Challenor J, Traub M (1995) Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. Br J Clin Pharmacol 39:235-242
30. McCann UD, Slate SO, Geraci M, Roscow-Terrill D, Uhde TW (1997) A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls. Neuropsychopharmacology 16:229-237
31. McNally RJ (1996) Anxiety sensitivity is distinguishable from trait anxiety. In: Rapee RM (ed) Current controversies in the anxiety disorder. The Guilford Press, New York, pp 215-227
32. Radu D, Åhlin A, Svanborg P, Lindefors N (2002) Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels. Psychopharmacology 161:396-403
33. Rapee RM, Medoro L (1994) Fear of physical sensations and trait anxiety as mediators of the response to hyperventilation in nonclinical subjects. J Abnorm Psychol 103:693-699
34. Reiss S, Peterson RA, Gursky DM, McNally RJ (1986) Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24:1-8
35. Rouillon F (1996) Epidemiology of panic disorder. Encephale 22[Suppl 5]:25-34
36. Sandin B, Chorot P, McNally RJ (2001) Anxiety sensitivity index: normative data and its differentiation from trait anxiety. Behav Res Ther 39:213-219
37. Schalling D, Åsberg M, Edman G, Oreland L (1987) Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 76:172-182
38. Schmidt NB, Cook JH (1999) Effects of anxiety sensitivity on anxiety and pain during a cold pressor challenge in patients with panic disorder. Behav Res Ther 37:313-323
39. Uvnäs-Moberg K, Arn I, Jonsson CO, Ek S, Nilsonne A (1993) The relationships between personality traits and plasma gastrin, cholecystokinin, somatostatin, insulin, and oxytocin levels in healthy women. J Psychosom Res 37:581-588
40. van Megen HJ, Westenberg HG, den Boer JA, Haigh JR, Traub M (1994) Pentagastrin-induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology 114:449-455
41. van Zijderveld GA, Veltman DJ, van Dyck R, van Doornen LJ (1999) Epinephrine-induced panic attacks and hyperventilation. J Psychiatr Res 33:73-78
42. Veltman DJ, van Zijderveld GA, van Dyck R, Bakker A (1998) Predictability, controllability, and fear of symptoms of anxiety in epinephrine-induced panic. Biol Psychiatry 44:1017-1026
43. Wittchen HU, Essau CA (1993) Epidemiology of panic disorder: progress and unresolved issues. J Psychiatr Res 27:47-68